Nuclear factor of activated T cells as a driver of tumor progression and a target for precision therapy
Animal Models and Experimental Medicine · 2026-07 · 9 (7) · 1338-1352
DOI: 10.1002/ame2.70251 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 01.07.2026. Verfasst von Hira Khan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, United Arab Emirates University, Al Ain, UAE. Hauptthemen laut MEDLINE: NFATC Transcription Factors, Neoplasms, Precision Medicine. Die Arbeit nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UAE University.
Abstract (Originalsprache)
The Nuclear Factor of Activated T Cells (NFAT) family comprises closely related transcription factors. Numerous biological processes including angiogenesis, invasion, migration, proliferation, and cell survival are regulated by the NFAT family. NFATs are overexpressed and have increased transcriptional activity in a variety of human solid tumors and hematological cancers. Beyond tumor cell‐intrinsic roles, NFAT has also emerged as an important regulator of the tumor microenvironment (TME), where it can influence immune cell behavior and contribute to mechanisms of immune evasion. The discovery of the multifaceted functions of NFATs has driven the need to further unveil their role in cancer and provide new insights into other potential roles. This review provides a comprehensive narrative synthesis of current molecular and clinical studies, with particular emphasis on how NFAT shapes tumor immune interactions and modulates the TME. By integrating findings across different cancer types, we highlight how NFAT may contribute to both tumor progression and immune regulation. The review concludes by highlighting significant knowledge gaps and recommending future paths for translational and therapeutic research to leverage NFAT signaling as a potential target in precision cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, College of Science, United Arab Emirates University, Al Ain, UAE.
- Department of Environmental Science and Sustainability, College of Natural and Health Sciences, Zayed University, Abu Dhabi, UAE.
- Department of Bioinformatics, Biozentrum Am Hubland, University of Würzburg, Würzburg, Germany.
- Department of Pathology, University of Würzburg, Würzburg, Germany.
- Zayed Bin Sultan Al Nahyan Center for Health Sciences, United Arab Emirates University, Al Ain, UAE.
ORCID-Profile: Khalid Muhammad
Förderung
- UAE University
Zitieren
APA
Khan, H., Alia, K., Al Dhaheri, Y., Naseem, M., Iratni, R., Serfling, E., & Muhammad, K. (2026). Nuclear factor of activated T cells as a driver of tumor progression and a target for precision therapy. Animal Models and Experimental Medicine, 9(7), 1338-1352. https://doi.org/10.1002/ame2.70251
Vancouver
Khan H, Alia K, Al Dhaheri Y, Naseem M, Iratni R, Serfling E, et al. Nuclear factor of activated T cells as a driver of tumor progression and a target for precision therapy. Animal Models and Experimental Medicine. 2026;9(7):1338-1352. doi:10.1002/ame2.70251
BibTeX
@article{Khan2026,
author = {Khan, Hira and Alia, Khushbakhat and Al Dhaheri, Yusra and Naseem, Muhammad and Iratni, Rabah and Serfling, Edgar and Muhammad, Khalid},
title = {Nuclear factor of activated T cells as a driver of tumor progression and a target for precision therapy},
journal = {Animal Models and Experimental Medicine},
year = {2026},
volume = {9},
number = {7},
pages = {1338--1352},
doi = {10.1002/ame2.70251}
}
EUVIMED